Steven C. Quay - May 21, 2025 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Signature
/s/ Steven C. Quay
Stock symbol
ATOS
Transactions as of
May 21, 2025
Transactions value $
$9,887
Form type
4
Date filed
5/22/2025, 06:27 PM
Previous filing
May 16, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
QUAY STEVEN C President & CEO, Director C/O ATOSSA THERAPEUTICS, INC.,, 10202 5TH AVE NE, SUITE 200, SEATTLE /s/ Steven C. Quay 2025-05-22 0001008227

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $0.8794 to $0.9100. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of share purchased at each separate price.
F2 Ensisheim Partners, LLC ("Ensisheim") is wholly owned by the Reporting Person and Dr. Shu-Chih Chen. The Reporting Person and Dr. Chen share voting and investment power over the securities held by Ensisheim. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.